Arcus Biosciences (RCUS) EPS (Basic) (2017 - 2026)
Arcus Biosciences' (RCUS) quarterly EPS (Basic) came in at -$1.02 in Q1 2026, up 10.32% year-on-year from -$0.93 in Q1 2025, and down 3.42% quarter-over-quarter from -$0.99 in Q4 2025.
Arcus Biosciences (RCUS) EPS (Basic) (2017 - 2026) Analysis & Trends
Arcus Biosciences' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$1.02 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 10.32% year-over-year to -$1.02 in Q1 2026; TTM through Mar 2026 was -$2.94, a 25.95% increase from a year earlier, with the FY2025 full-year figure at -$3.29, down 4.64% from the prior year.
- EPS (Basic) slipped to -$1.02 in Q1 2026 per RCUS's latest filing, from -$0.99 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.05 in Q1 2024 and bottomed at -$1.27 in Q3 2025.
- The 5-year median for EPS (Basic) is -$1.01 (2024), against an average of -$0.96.
- Across the five-year window, EPS (Basic) soared 95.77% in 2024 and slumped 2352.85% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.93 in 2022, then decreased by 17.63% to -$1.09 in 2023, then advanced by 4.69% to -$1.04 in 2024, then rose by 5.4% to -$0.99 in 2025, then declined by 3.42% to -$1.02 in 2026.
- Per Business Quant, the three latest RCUS EPS (Basic) figures stand at -$1.02 (Q1 2026), -$0.99 (Q4 2025), and -$1.27 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | -1.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.02 |
| Dec 31, 2025 | -0.99 |
| Sep 30, 2025 | -1.27 |
| Mar 31, 2025 | -1.14 |
| Dec 31, 2024 | -1.04 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.02 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | -1.09 |
| Sep 30, 2023 | -0.95 |
| Jun 30, 2023 | -1.02 |
| Mar 31, 2023 | -1.10 |
| Dec 31, 2022 | -0.93 |
| Sep 30, 2022 | -0.90 |
| Jun 30, 2022 | -0.93 |
| Mar 31, 2022 | -0.96 |
| Dec 31, 2021 | 4.03 |
| Sep 30, 2021 | -1.09 |
| Jun 30, 2021 | -1.07 |
| Mar 31, 2021 | -1.06 |